Skip to main content
Top
Published in: Cancer Cell International 1/2022

Open Access 01-12-2022 | Epstein-Barr Virus | Research

Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China

Authors: Siwei Miao, Haike Lei, Xiaosheng Li, Wei Zhou, Guixue Wang, Anlong Sun, Ying Wang, Yongzhong Wu

Published in: Cancer Cell International | Issue 1/2022

Login to get access

Abstract

Objective

Nasopharyngeal carcinoma (NPC) is prevailing in Southern China, characterized by distinct geographical distribution. Aimed to predict the overall survival (OS) of patients with nasopharyngeal carcinoma, this study developed and validated nomograms considering demographic variables, hematological biomarkers, and oncogenic pathogens in China.

Methods

The clinicopathological and follow-up data of the nasopharyngeal carcinoma patients obtained from a prospective longitudinal cohort study in the Chongqing University Cancer Hospital between Jan 1, 2017 and Dec 31, 2019 (\(\mathrm{n}=1635\)). Cox regression model was used to tested the significance of all available variables as prognostic factors of OS. And independent prognostic factors were identified based on multivariable analysis to model nomogram. Concordance index (C-index), area under the receiver operating characteristic (AUC), calibration curve, and decision curve analysis (DCA) were measured to assess the model performance of nomogram.

Results

Data was randomly divided into a training cohort (1227 observers, about 70% of data) and a validation group (408 observers, about 30% of data). At multivariable analysis, the following were independent predictors of OS in NPC patients and entered into the nomogram: age (hazard ratio [HR]: 1.03), stage (stage IV vs. stage I–II, HR: 4.54), radiotherapy (Yes vs. No, HR: 0.43), EBV (\(\ge 1000\) vs.\(<1000\), HR: 1.92), LAR (\(>6.15\) vs.\(\le 6.15\), HR: 2.05), NLR (\(>4.84\) vs. \(\le 4.84\) HR: 1.54), and PLR (\(>206.33\) vs.\(\le 206.33\), HR: 1.79). The C-indexes for training cohort at 1-, 3- and 5-year were 0.73, 0.83, 0.80, respectively, in the validation cohort, the C-indexes were 0.74 (95% CI 0.63–0.86), 0.80 (95% CI 0.73–0.87), and 0.77 (95% CI 0.67–0.86), respectively. The calibration curve demonstrated that favorable agreement between the predictions of the nomograms and the actual observations in the training and validation cohorts. In addition, the decision curve analysis proved that the nomogram model had the highest overall net benefit.

Conclusion

A new prognostic model to predict OS of patients with NPC was developed. This can offer clinicians treatment making and patient counseling. Furthermore, the nomogram was deployed into a website server for use.
Literature
1.
go back to reference Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.CrossRefPubMed Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.CrossRefPubMed
2.
go back to reference Tang L-L, Chen Y-P, Chen C-B, Chen M-Y, Chen N-Y, Chen X-Z, et al. The Chinese society of clinical oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun. 2021;41(11):1195–227.CrossRef Tang L-L, Chen Y-P, Chen C-B, Chen M-Y, Chen N-Y, Chen X-Z, et al. The Chinese society of clinical oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun. 2021;41(11):1195–227.CrossRef
3.
go back to reference Yang D, Bin N, Zhou Z, Li Z, Shen M, Yang C, et al. Demographics and economic burden of nasopharyngeal carcinoma inpatients. Biomed Res Int. 2022;2022:6958806.PubMedPubMedCentral Yang D, Bin N, Zhou Z, Li Z, Shen M, Yang C, et al. Demographics and economic burden of nasopharyngeal carcinoma inpatients. Biomed Res Int. 2022;2022:6958806.PubMedPubMedCentral
4.
go back to reference Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1204–22.CrossRef Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1204–22.CrossRef
5.
6.
go back to reference Carioli G, Negri E, Kawakita D, Garavello W, La Vecchia C, Malvezzi M. Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas. Int J Cancer. 2017;140(10):2256–64.CrossRefPubMed Carioli G, Negri E, Kawakita D, Garavello W, La Vecchia C, Malvezzi M. Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas. Int J Cancer. 2017;140(10):2256–64.CrossRefPubMed
7.
go back to reference Zhang T, Chen Z, Deng J, Xu K, Che D, Lin J, et al. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma. Cell Death Dis. 2022;13(7):664.CrossRefPubMedPubMedCentral Zhang T, Chen Z, Deng J, Xu K, Che D, Lin J, et al. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma. Cell Death Dis. 2022;13(7):664.CrossRefPubMedPubMedCentral
8.
go back to reference Xu M, Zang J, Luo S, Wang J, Li X. Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study. BMJ Open. 2021;11(8):e045417.CrossRefPubMedPubMedCentral Xu M, Zang J, Luo S, Wang J, Li X. Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study. BMJ Open. 2021;11(8):e045417.CrossRefPubMedPubMedCentral
9.
go back to reference Peng RR, Liang ZG, Chen KH, Li L, Qu S, Zhu XD. Nomogram based on lactate dehydrogenase-to-albumin ratio (LAR) and platelet-to-lymphocyte ratio (PLR) for predicting survival in nasopharyngeal carcinoma. J Inflamm Res. 2021;14:4019–33.CrossRefPubMedPubMedCentral Peng RR, Liang ZG, Chen KH, Li L, Qu S, Zhu XD. Nomogram based on lactate dehydrogenase-to-albumin ratio (LAR) and platelet-to-lymphocyte ratio (PLR) for predicting survival in nasopharyngeal carcinoma. J Inflamm Res. 2021;14:4019–33.CrossRefPubMedPubMedCentral
10.
go back to reference Gundog M, Basaran H. The prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in nasopharyngeal cancer. J BUON. 2020;25(1):367–75.PubMed Gundog M, Basaran H. The prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in nasopharyngeal cancer. J BUON. 2020;25(1):367–75.PubMed
11.
go back to reference Ye L, Oei RW, Kong F, Xu T, Shen C, Wang X, et al. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Eur Arch Otorhinolaryngol. 2018;275(5):1309–17.CrossRefPubMedPubMedCentral Ye L, Oei RW, Kong F, Xu T, Shen C, Wang X, et al. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Eur Arch Otorhinolaryngol. 2018;275(5):1309–17.CrossRefPubMedPubMedCentral
12.
go back to reference Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol. 1995;16(2):103–8.CrossRefPubMed Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol. 1995;16(2):103–8.CrossRefPubMed
13.
go back to reference Luo WJ, He SW, Zou WQ, Zhao Y, He QM, Yang XJ, et al. Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7. Exp Biol Med (Maywood). 2021;246(24):2618–29.CrossRef Luo WJ, He SW, Zou WQ, Zhao Y, He QM, Yang XJ, et al. Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7. Exp Biol Med (Maywood). 2021;246(24):2618–29.CrossRef
14.
go back to reference Wu J, Zhou Q, Pan Z, Wang Y, Hu L, Chen G, et al. Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: a population-based study. Medicine. 2020;99(4): e18974.CrossRefPubMedPubMedCentral Wu J, Zhou Q, Pan Z, Wang Y, Hu L, Chen G, et al. Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: a population-based study. Medicine. 2020;99(4): e18974.CrossRefPubMedPubMedCentral
15.
go back to reference Huang ZZ, Wen W, Hua X, Song CG, Bi XW, Huang JJ, et al. Establishment and validation of nomogram based on combination of pretreatment C-reactive protein/albumin ratio-EBV DNA Grade in nasopharyngeal carcinoma patients who received concurrent chemoradiotherapy. Front Oncol. 2021;11: 583283.CrossRefPubMedPubMedCentral Huang ZZ, Wen W, Hua X, Song CG, Bi XW, Huang JJ, et al. Establishment and validation of nomogram based on combination of pretreatment C-reactive protein/albumin ratio-EBV DNA Grade in nasopharyngeal carcinoma patients who received concurrent chemoradiotherapy. Front Oncol. 2021;11: 583283.CrossRefPubMedPubMedCentral
16.
go back to reference Huang SJ, Tang YY, Liu HM, Tan GX, Wang X, Zhang H, et al. Impact of age on survival of locoregional nasopharyngeal carcinoma: an analysis of the surveillance, epidemiology, and end results program database, 2004–2013. Clin Otolaryngol. 2018;43(5):1209–18.CrossRefPubMed Huang SJ, Tang YY, Liu HM, Tan GX, Wang X, Zhang H, et al. Impact of age on survival of locoregional nasopharyngeal carcinoma: an analysis of the surveillance, epidemiology, and end results program database, 2004–2013. Clin Otolaryngol. 2018;43(5):1209–18.CrossRefPubMed
17.
go back to reference Wang J, Huang X, Sun S, Wang K, Qu Y, Chen X, et al. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: clinical implications for treatment strategies and surveillance. Cancer Med. 2021;10(11):3613–21.CrossRefPubMedPubMedCentral Wang J, Huang X, Sun S, Wang K, Qu Y, Chen X, et al. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: clinical implications for treatment strategies and surveillance. Cancer Med. 2021;10(11):3613–21.CrossRefPubMedPubMedCentral
18.
go back to reference Zhao R, Liang Z, Chen K, Zhu X. Nomogram based on inflammatory biomarkers and nutritional indicators for predicting overall survival in locoregionally advanced nasopharyngeal carcinoma. J Inflamm Res. 2022;15:2971–81.CrossRefPubMedPubMedCentral Zhao R, Liang Z, Chen K, Zhu X. Nomogram based on inflammatory biomarkers and nutritional indicators for predicting overall survival in locoregionally advanced nasopharyngeal carcinoma. J Inflamm Res. 2022;15:2971–81.CrossRefPubMedPubMedCentral
19.
go back to reference Ooft ML, van Ipenburg JA, Braunius WW, Zuur CI, Koljenović S, Willems SM. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma. Oral Oncol. 2017;71:16–25.CrossRefPubMed Ooft ML, van Ipenburg JA, Braunius WW, Zuur CI, Koljenović S, Willems SM. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma. Oral Oncol. 2017;71:16–25.CrossRefPubMed
20.
go back to reference Ooft ML, van Ipenburg JA, Sanders ME, Kranendonk M, Hofland I, de Bree R, et al. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma. J Clin Pathol. 2018;71(3):267–74.CrossRefPubMed Ooft ML, van Ipenburg JA, Sanders ME, Kranendonk M, Hofland I, de Bree R, et al. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma. J Clin Pathol. 2018;71(3):267–74.CrossRefPubMed
22.
go back to reference Li J, Wu YL, Li WF, Ma J. Neutrophil to apolipoprotein A-I ratio as an independent indicator of locally advanced nasopharyngeal carcinoma. Laryngoscope Investig Otolaryngol. 2021;6(5):1049–61.CrossRefPubMedPubMedCentral Li J, Wu YL, Li WF, Ma J. Neutrophil to apolipoprotein A-I ratio as an independent indicator of locally advanced nasopharyngeal carcinoma. Laryngoscope Investig Otolaryngol. 2021;6(5):1049–61.CrossRefPubMedPubMedCentral
23.
go back to reference Li Q, Yu L, Yang P, Hu Q. Prognostic value of inflammatory markers in nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era. Cancer Manag Res. 2021;13:6799–810.CrossRefPubMedPubMedCentral Li Q, Yu L, Yang P, Hu Q. Prognostic value of inflammatory markers in nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era. Cancer Manag Res. 2021;13:6799–810.CrossRefPubMedPubMedCentral
24.
go back to reference Reffai A, Mesmoudi M, Derkaoui T, Ghailani Nourouti N, Barakat A, Sellal N, et al. Epidemiological profile and clinicopathological, therapeutic, and prognostic characteristics of nasopharyngeal carcinoma in Northern Morocco. Cancer Control. 2021;28:10732748211050588.CrossRefPubMedPubMedCentral Reffai A, Mesmoudi M, Derkaoui T, Ghailani Nourouti N, Barakat A, Sellal N, et al. Epidemiological profile and clinicopathological, therapeutic, and prognostic characteristics of nasopharyngeal carcinoma in Northern Morocco. Cancer Control. 2021;28:10732748211050588.CrossRefPubMedPubMedCentral
25.
go back to reference Zhang Y, Chen L, Hu G-Q, Zhang N, Zhu X-D, Yang K-Y, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381(12):1124–35.CrossRefPubMed Zhang Y, Chen L, Hu G-Q, Zhang N, Zhu X-D, Yang K-Y, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381(12):1124–35.CrossRefPubMed
26.
go back to reference Ma BBY, Chen YP, Hui EP, Liu X, Chan AKC, Chan ATC, et al. Recent advances in the development of biomarkers and chemoradiotherapeutic approaches for nasopharyngeal carcinoma. Am Soc Clin Oncol Educ Book. 2020;40:1–11.PubMed Ma BBY, Chen YP, Hui EP, Liu X, Chan AKC, Chan ATC, et al. Recent advances in the development of biomarkers and chemoradiotherapeutic approaches for nasopharyngeal carcinoma. Am Soc Clin Oncol Educ Book. 2020;40:1–11.PubMed
Metadata
Title
Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China
Authors
Siwei Miao
Haike Lei
Xiaosheng Li
Wei Zhou
Guixue Wang
Anlong Sun
Ying Wang
Yongzhong Wu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2022
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-022-02776-8

Other articles of this Issue 1/2022

Cancer Cell International 1/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine